Possible Arbitrage Play Develops as Amgen (NASDAQ: AMGN) buys Micromet (NASDAQ: MITI) - Howard B. Arnn (01/26/12)

This morning before the start of trading on the New York Stock Exchange and Nasdaq Amgen (NASDAQ: AMGN) announced that it was purchasing biotech company Micromet Incorporated (NASDAQ: MITI) for a blockbuster $1.16 billion acquisition.

Micromet announced that it also agreed to the buyout and shareholders will receive $11 in cash per every share that they own.

On that news MITI shares exploded for a nice gain of over 31% on the trading open, which I'm sure brought much joy to investors in the company.


What makes the deal attractive for Amgen is that it will give them control of the drug blinatumomab, which Micromet has been developing to treat lympgoblastic leukemia and non-Hodgkins's lymphoma. It is in a Phase 2 clinical trial.
MITI shares have noted trade at $11 per shares in 2006 and have been below the $9.00 level for the past twelve months.

At the moment MITI is trading below $11 at $10.91 so it is proving a little arbitrage play for people who want to take advantage of it.

For more:

Podcast: Markus Heitkoetter of RockwellTrading.com on His Daytrading Tactics, Indicators, and Range Base Trading Strategies - Mike Swanson (01/26/12)

Podcast: David Banister of MarketTrendForecast.com Talks About a Likely Stock Market Pullback and Then Another Move Higher - Mike Swanson (01/25/12)

Podcast: Victor Riesco on the Current Stock Market Rally and His Recent Trades - Mike Swanson (01/20/12)

Podcast: Mike "Tiny" Saul Talks About How Stocks Respond to Earnings and His Take on the Stock Market - Mike Swanson (01/18/12)

Podcast: David Morgan on Silver Investing in 2012 - Mike Swanson (01/15/12)

Podcast: Jeff Pierce of Zentrader.ca Talks about the Bond Market and Financial Blogging - Mike Swanson (01/14/12)

Grab This Free Report: My Top Options Trading Setup

This free special WSW report is devoted to my top options trading setup. I do this one simple trade at least once a month.

Grab it and get along with it our future stock market action updates. Do not think about buying any other stocks or options before you read this report. To get this report click here